Structural and functional retinal changes in patients with type 2 diabetes without diabetic retinopathy

References

• American Academy of Ophthalmology. Diabetic retinopathy preferred practice pattern – updated 2019. San Francisco: American Academy of Ophthalmology; 2019.
   Google Scholar
• Yau JWY, Rogers SL, Kawasaki R, Meta-Analysis for Eye Disease (META-EYE) Study Group, et al. Global prevalence and major risk factors of diabetic retinopathy. Diabetes Care. 2012;35(3):556–564.
   PubMed Web of Science ®Google Scholar
• Wong TY, Cheung CMG, Larsen M, et al. Diabetic retinopathy. Nat Rev Dis Primers. 2016;2:16012.
   PubMed Web of Science ®Google Scholar
• American Diabetes Association. 11. Microvascular complications and foot care: standards of medical care in diabetes-2021. Diabetes Care. 2021;44(Suppl 1):S151–S167.
   PubMed Web of Science ®Google Scholar
• Yang JY, Wang Q, Yan YN, et al. Microvascular retinal changes in preclinical diabetic retinopathy as detected by optical coherence tomographic angiography. Graefes Arch Clin Exp Ophthalmol. 2020;258(3):513–520.
   PubMed Web of Science ®Google Scholar
• Chen X, Nie C, Gong Y, et al. Peripapillary retinal nerve fiber layer changes in preclinical diabetic retinopathy: a meta-analysis. PLOS One. 2015;10(5):e0125919.
   PubMed Web of Science ®Google Scholar
• Gonul S, et al. Evaluation of retinal nerve fiber layer thickness with optical coherence tomography in type 1 diabetes mellitus patients. Turkiye Klinikleri J Med Sci. 2011;31:1100–1105.
   Google Scholar
• Peng PH, Lin HS, Lin S. Nerve fibre layer thinning in patients with preclinical retinopathy. Can J Ophthalmol. 2009;44(4):417–422.
   PubMed Web of Science ®Google Scholar
• Park HY, Kim IT, Park CK. Early diabetic changes in the nerve fibre layer at the macula detected by spectral domain optical coherence tomography. Br J Ophthalmol. 2011;95(9):1223–1228.
   PubMed Web of Science ®Google Scholar
• Sugimoto M, Sasoh M, Ido M, et al. Detection of early diabetic change with optical coherence tomography in type 2 diabetes mellitus patients without retinopathy. Ophthalmologica. 2005;219(6):379–385.
   PubMed Web of Science ®Google Scholar
• Lung JCY, Swann PG, Wong DSH, et al. Global flash multifocal electroretinogram: early detection of local functional changes and its correlations with optical coherence tomography and visual field tests in diabetic eyes. Doc Ophthalmol. 2012;125(2):123–135.
   PubMed Web of Science ®Google Scholar
• Xin C, Wang J, Meng X, et al. Effect on the retinal fiber thickness in early diabetes. Zhonghua Yi Xue Za Zhi. 2014;94(3):208–211.
   PubMedGoogle Scholar
• Ma J, et al. Correlation of optic retinal nerve fiber layer thickness and visual function in patients with nonproliferative diabetic retinopathy. Zhonghua Yan Ke Za Zhi. 2013;49(6):514–520.
   PubMedGoogle Scholar
• Oshitari T, Hanawa K, Adachi-Usami E. Changes of macular and RNFL thicknesses measured by stratus OCT in patients with early stage diabetes. Eye. 2009;23(4):884–889.
   PubMed Web of Science ®Google Scholar
• Li Z, Wen X, Zeng P, et al. Do microvascular changes occur preceding neural impairment in early-stage diabetic retinopathy? Evidence based on the optic nerve head using optical coherence tomography angiography. Acta Diabetol. 2019;56(5):531–539.
   PubMed Web of Science ®Google Scholar
• Kim K, Kim ES, Kim DG, et al. Progressive retinal neurodegeneration and microvascular change in diabetic retinopathy: longitudinal study using OCT angiography. Acta Diabetol. 2019;56(12):1275–1282.
   PubMed Web of Science ®Google Scholar
• Pires I, Bernardes RC, Lobo CL, et al. Retinal thickness in eyes with mild nonproliferative retinopathy in patients with type 2 diabetes mellitus: comparison of measurements obtained by retinal thickness analysis and optical coherence tomography. Arch Ophthalmol. 2002;120(10):1301–1306.
   PubMedGoogle Scholar
• Park JC, Chen Y-F, Liu M, et al. Structural and functional abnormalities in early-stage diabetic retinopathy. Curr Eye Res. 2020;45(8):975–985.
   PubMed Web of Science ®Google Scholar
• Gella L, Raman R, Kulothungan V, et al. Retinal sensitivity in subjects with type 2 diabetes mellitus: Sankara nethralaya diabetic retinopathy epidemiology and molecular genetics study (SN-DREAMS II, report No. 4). Br J Ophthalmol. 2016;100(6):808–813.
   PubMed Web of Science ®Google Scholar
• Zeng Y, et al. Early retinal neurovascular impairment in patients with diabetes without clinically detectable retinopathy. Br J Ophthalmol. 2019;103(12):1747–1752.
   PubMed Web of Science ®Google Scholar
• Wilkinson CP, Ferris FL, Klein RE, Global Diabetic Retinopathy Project Group, et al. Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales. Ophthalmology. 2003;110(9):1677–1682.
   PubMed Web of Science ®Google Scholar
• Palkovits S, Hirnschall N, Georgiev S, et al. Effect of cataract extraction on retinal sensitivity measurements. Ophthalmic Res. 2021;64(1):10–14.
   PubMed Web of Science ®Google Scholar
• Verma A, Rani PK, Raman R, et al. Is neuronal dysfunction an early sign of diabetic retinopathy? Microperimetry and spectral domain optical coherence tomography (SD-OCT) study in individuals with diabetes, but no diabetic retinopathy. Eye. 2009;23(9):1824–1830.
   PubMed Web of Science ®Google Scholar
• Neriyanuri S, Pardhan S, Gella L, et al. Retinal sensitivity changes associated with diabetic neuropathy in the absence of diabetic retinopathy. Br J Ophthalmol. 2017;101(9):1174–1178.
   PubMed Web of Science ®Google Scholar
• Altmann C, Schmidt MHH. The role of microglia in diabetic retinopathy: inflammation, microvasculature defects and neurodegeneration. Int J Mol Sci. 2018;19(1):110.
   PubMed Web of Science ®Google Scholar
• Barber AJ. A new view of diabetic retinopathy: a neurodegenerative disease of the eye. Prog Neuropsychopharmacol Biol Psychiatry. 2003;27(2):283–290.
   PubMed Web of Science ®Google Scholar
• Mehboob MA, Amin ZA, Islam QU. Comparison of retinal nerve fiber layer thickness between normal population and patients with diabetes mellitus using optical coherence tomography. Pak J Med Sci. 2019;35(1):29–33.
   PubMed Web of Science ®Google Scholar
• Karti O, Nalbantoglu O, Abali S, et al. Retinal ganglion cell loss in children with type 1 diabetes mellitus without diabetic retinopathy. Ophthalmic Surg Lasers Imaging Retina. 2017;48(6):473–477.
   PubMed Web of Science ®Google Scholar
• Sohn EH, van Dijk HW, Jiao C, et al. Retinal neurodegeneration may precede microvascular changes characteristic of diabetic retinopathy in diabetes mellitus. Proc Natl Acad Sci USA. 2016;113(19):E2655–64.
   PubMed Web of Science ®Google Scholar
• Lopes de Faria JM, Russ H, Costa VP. Retinal nerve fibre layer loss in patients with type 1 diabetes mellitus without retinopathy. Br J Ophthalmol. 2002;86(7):725–728.
   PubMed Web of Science ®Google Scholar
• Dhasmana R, Sah S, Gupta N. Study of retinal nerve fibre layer thickness in patients with diabetes mellitus using Fourier domain optical coherence tomography. J Clin Diagn Res. 2016;10(7):NC05–9.
   Google Scholar
• Oliverio GW, Ceravolo I, Bhatti A, et al. Foveal avascular zone analysis by optical coherence tomography angiography in patients with type 1 and 2 diabetes and without clinical signs of diabetic retinopathy. Int Ophthalmol. 2021;41(2):649–658.
   PubMed Web of Science ®Google Scholar
• Fleissig E, Adhi M, Sigford DK, et al. Foveal vasculature changes and nonperfusion in patients with diabetes types I and II with no evidence of diabetic retinopathy. Graefes Arch Clin Exp Ophthalmol. 2020;258(3):551–556.
   PubMed Web of Science ®Google Scholar
• Tang FY, Ng DS, Lam A, et al. Determinants of quantitative optical coherence tomography angiography metrics in patients with diabetes. Sci Rep. 2017;7(1):2575.
   PubMedGoogle Scholar
• Durbin MK, An L, Shemonski ND, et al. Quantification of retinal microvascular density in optical coherence tomographic angiography images in diabetic retinopathy. JAMA Ophthalmol. 2017;135(4):370–376.
   PubMed Web of Science ®Google Scholar
• Takase N, Nozaki M, Kato A, et al. Enlargement of foveal avascular zone in diabetic eyes evaluated by en face optical coherence tomography angiography. Retina. 2015;35(11):2377–2383.
   PubMed Web of Science ®Google Scholar
• Lee J, Moon BG, Cho AR, et al. Optical coherence tomography angiography of DME and its association with anti-VEGF treatment response. Ophthalmology. 2016;123(11):2368–2375.
   PubMed Web of Science ®Google Scholar
• Mastropasqua R, et al. Foveal avascular zone area and parafoveal vessel density measurements in different stages of diabetic retinopathy by optical coherence tomography angiography. Int J Ophthalmol. 2017;10(10):1545–1551.
   PubMed Web of Science ®Google Scholar
• Lupidi M, Coscas G, Coscas F, et al. Retinal microvasculature in nonproliferative diabetic retinopathy: Automated quantitative optical coherence tomography angiography assessment. Ophthalmic Res. 2017;58(3):131–141.
   PubMed Web of Science ®Google Scholar
• Simonett JM, Scarinci F, Picconi F, et al. Early microvascular retinal changes in optical coherence tomography angiography in patients with type 1 diabetes mellitus. Acta Ophthalmol. 2017;95(8):e751–e755.
   PubMed Web of Science ®Google Scholar
• Shin Y-I, Nam KY, Lee SE, et al. Peripapillary microvasculature in patients with diabetes mellitus: an optical coherence tomography angiography study. Sci Rep. 2019;9(1):15814.
   PubMedGoogle Scholar
• Robinson R, Barathi VA, Chaurasia SS, et al. Update on animal models of diabetic retinopathy: from molecular approaches to mice and higher mammals. Dis Model Mech. 2012;5(4):444–456.
   PubMed Web of Science ®Google Scholar
• Kim JS. The microperimetry of resolved cotton-wool spots in eyes of patients with hypertension and diabetes mellitus. Arch Ophthalmol. 2011;129(7):879–884.
   PubMedGoogle Scholar
• Zhang B, Chou Y, Zhao X, et al. Early detection of microvascular impairments with optical coherence tomography angiography in diabetic patients without clinical retinopathy: a meta-analysis. Am J Ophthalmol. 2021;222:226–237.
   PubMed Web of Science ®Google Scholar
• Cade WT. Diabetes-related microvascular and macrovascular diseases in the physical therapy setting. Phys Ther. 2008;88(11):1322–1335.
   PubMed Web of Science ®Google Scholar
• Matsunaga DR, Yi JJ, De Koo LO, et al. Optical coherence tomography angiography of diabetic retinopathy in human subjects. Ophthalmic Surg Lasers Imaging Retina. 2015;46(8):796–805.
   PubMed Web of Science ®Google Scholar
• Miyamoto K, Khosrof S, Bursell SE, et al. Prevention of leukostasis and vascular leakage in streptozotocin-induced diabetic retinopathy via intercellular adhesion molecule-1 inhibition. Proc Natl Acad Sci USA. 1999;96(19):10836–10841.
   PubMed Web of Science ®Google Scholar
• Srinivasan S, Rajalakshmi R, Anjana RM, et al. Retinal structure-function correlation in type 2 diabetes. Eye(Lond). 2021.
   Google Scholar